Novanta (NOVT) stock: Winston Score, insiders and Congress trades
Novanta Inc. makes precision motion and sensing components used inside medical and industrial machines. Its products include laser scanning systems, motion control parts, and surgical robotics components. The company sells mainly to medical device makers and industrial automation companies, making it a behind-the-scenes supplier inside equipment like robotic surgery systems and factory robots. Novanta earns money by selling hardware components and subsystems to original equipment manufacturers, meaning its customers build Novanta's parts into their own finished products. The company operates primarily in North America and Europe and generates roughly $1 billion in annual revenue. Its competitive edge comes from deep engineering relationships with customers, who tend to design Novanta's parts directly into their products — making it costly to switch suppliers. The key growth driver is rising demand for surgical robotics and factory automation, though a slowdown in medical device spending or capital equipment budgets could pressure sales.
Winston Score: 44 out of 100, Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (12/30)
- Growth: Mixed (5/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (9/10)
- Valuation: Good (5/10)
- Ownership: Weak (2/15)
Key Facts
Price: $141.28
Market Cap: $5.0B
Sector: Technology
Industry: Hardware, Equipment & Parts
Exchange: NASDAQ
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-09.



